These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 15214038

  • 1. Neonatal tolerance revisited again: specific CTL priming in mouse neonates exposed to small numbers of semi- or fully allogeneic spleen cells.
    Adkins B, Jones M, Bu Y, Levy RB.
    Eur J Immunol; 2004 Jul; 34(7):1901-9. PubMed ID: 15214038
    [Abstract] [Full Text] [Related]

  • 2. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A, Merino R, Merino J.
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [Abstract] [Full Text] [Related]

  • 3. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G, Schurmans S, Berney M, Izui S, del Giudice G, Lambert PH.
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [Abstract] [Full Text] [Related]

  • 4. Anti-LFA-1 (CD11a) monoclonal antibody interferes with neonatal induction of tolerance to alloantigens.
    Schurmans S, Gonzalez A, Revilla C, Ramos A, Lambert PH, Merino J.
    Eur J Immunol; 1994 Apr; 24(4):985-90. PubMed ID: 7908637
    [Abstract] [Full Text] [Related]

  • 5. CD4+ T cells determine the ability of spleen cells from F1 hybrid mice to induce neonatal tolerance to alloantigens and autoimmunity in parental mice.
    González M, Schurmans S, Ramos A, Merino R, Lambert PH, Merino J.
    Eur J Immunol; 1995 Jun; 25(6):1760-4. PubMed ID: 7615004
    [Abstract] [Full Text] [Related]

  • 6. Characterization of host CD4+ T lymphocytes in mice neonatally tolerized to alloantigens.
    Kramar G, Aguado T, Louis J, del Giudice G, Lambert PH.
    Eur J Immunol; 1993 Oct; 23(10):2551-6. PubMed ID: 8104795
    [Abstract] [Full Text] [Related]

  • 7. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA, Flye MW.
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [Abstract] [Full Text] [Related]

  • 8. Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.
    Ramos A, González M, López-Hoyos M, Carrió R, Merino J.
    Immunology; 1996 Nov; 89(3):413-8. PubMed ID: 8958055
    [Abstract] [Full Text] [Related]

  • 9. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C, Ishizaka ST, Stutman O.
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity and in vivo correlates of alloantigen-specific murine suppressor T cells induced by allogeneic pregnancy.
    Nagarkatti PS, Clark DA.
    J Immunol; 1983 Aug; 131(2):638-43. PubMed ID: 6223087
    [Abstract] [Full Text] [Related]

  • 11. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM, Eaton VL, Lerret NM, Correa LA, Decresce RP, García LF, Jaramillo A.
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [Abstract] [Full Text] [Related]

  • 12. Induction of early alloantigen tolerance in thymus and spleen.
    Schwartz DH, Doherty PC.
    Thymus; 1984 May; 6(1-2):105-20. PubMed ID: 6235644
    [Abstract] [Full Text] [Related]

  • 13. Anti-Ia treatment prevents lupus-like autoimmune syndrome in mice neonatally tolerized to alloantigens.
    Kramar G, Schurmans S, Aguado T, Izui S, Del Giudice G, Lambert PH.
    J Autoimmun; 1993 Feb; 6(1):27-37. PubMed ID: 8096138
    [Abstract] [Full Text] [Related]

  • 14. Activation of thymic T cells by MHC alloantigen requires syngeneic, activated CD4+ T cells and B cells as APC.
    Strutt TM, Uzonna J, McKinstry KK, Bretscher PA.
    Int Immunol; 2006 May; 18(5):719-28. PubMed ID: 16569677
    [Abstract] [Full Text] [Related]

  • 15. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM, Ma Y, Wang S, Min WP, Zhong R, Jevnikar A, Zhang ZX.
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic T cell responses to minor H-43 alloantigens in H-43a and H-43b mice. Distinctive MHC class I restriction specificity and clonal inactivation are inherent properties of the H-43 system.
    Ishikawa H, Hayakawa J, Shiohara T.
    J Immunol; 1993 Sep 01; 151(5):2436-43. PubMed ID: 8360472
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 01; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 18. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X, Tyerman K, Ang A, Koo K, Parameswaran K, Tao K, Mai L, Lang H, West LJ.
    Transplant Proc; 2005 Nov 01; 37(1):29-31. PubMed ID: 15808536
    [Abstract] [Full Text] [Related]

  • 19. Antigen-specific protection against graft-vs-host induced immune deficiency.
    Iwasaki T, Hallam JA, Joseph LJ, Shearer GM.
    J Immunol; 1987 Jun 01; 138(11):3604-10. PubMed ID: 3035009
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y, Fujino M, Wang Q, Kimura H, Azuma M, Kubo M, Abe R, Li XK.
    Transplantation; 2007 Mar 27; 83(6):774-82. PubMed ID: 17414712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.